Treatment of traumatic optic neuropathy with high-dose corticosteroid

Journal of Neuro-Ophthalmology

Volumn 26, Issue 1, 2006, Pages 65-67

  Steinsapir, Kenneth D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; GLUCOCORTICOID;

BRAIN INJURY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HEAD INJURY; HUMAN; MORTALITY; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SHORT SURVEY; SPINAL CORD INJURY; ANIMAL; OPTIC NERVE INJURY; REVIEW; TREATMENT OUTCOME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; OPTIC NERVE INJURIES; TREATMENT OUTCOME;

EID: 33646833623     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wno.0000204646.94991.68     Document Type: Short Survey

References (23)

1. Levin LA, Baker RS. Management of traumatic optic neuropathy. J Neuroophthalmol 2003;23:72-5.
2. Levin LA, Beck RW, Joseph MP, et al. The treatment of traumatic optic neuropathy: the international optic nerve trauma study. Ophthalmology 1999;106:1268-77.
3. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11.
4. Bracken MB, Shepard MJ, Holford TR, et al. Administration of mehtylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.
5. Steinsapir KD, Goldberg RA. Traumatic optic neuropathy: A critical update. Comp Ophthalmol Update 2005;6:11-2.
6. Demopoulos HB, Flamm ES, Pietronigro DD, Seligman ML. The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand Suppl 1980;492:91-119.
7. Flamm ES, Demopoulos HB, Seligman ML, et al. Free radicals in cerebral ischemia. Stroke 1978;9:445-7.
8. Demopoulos HB, Flamm ES, Seligman ML, et al. Further studies on free-radical pathology in the major central nervous system disorders: Effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can J Physiol Pharmacol 1982;60:1415-24.
9. Hall ED, Braughler JM. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rational. Surg Neurol 1982;18:320-7.
10. Anderson DK, Means ED, Waters TR, et al. Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment. J Neurosurg 1982;56:106-13.
11. Braughler JM, Hall ED. Effects of multidose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J Nurosurg 1984;61:290-5.
12. Braughler JM, Hall ED, Means ED, et al. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 1987;67:102-5.
13. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurologic function in NASCIS 2. J Neurosurg 1993;79:500-7.
14. Ohlsson M, Mattsson P, Svensson M. A temporal study of axonal degeneration and glial scar formation following a standardized crush injury of the optic nerve in the adult rat. Restor Neurol Neurosci 2004;22:1-10.
15. Ohlsson M, Westerlund U, Langmoen IA, Svensson M. Methylprednisolone treatment does not influence axonal regeneration or degeneration following optic nerve injury in the adult rat. J Neuroophthalmol 2004;24:11-8.
16. Sheng Y, Zhu Y, Wu L. Effect of high dosage methylprednisolone on rat retinal ganglion cell apoptosis after optic nerve crush. Eye Science 2004;20:181-6.
17. Steinsapir KD, Goldberg RA, Sinha S, Hovda D. Methylprednisolone exacerbates axonal loss following optic nerve trauma in rats. Restor Neurol Neurosci 2000;17:157-63.
18. Diem R, Hobom M, Maier K, et al. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neuroscience 2003;23:6993-7000.
19. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care. J Neurosurg 2000;93:S1-S7.
20. Coleman WP, Benzel D, Cahill DW, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 2000;13:185-99.
21. Short DJ, El Masry WS, Jones PW. High-dose methylprednisolone in the mangement of acute spinal cord injury-a systematic review from a clincal perspective. Spinal Cord 2000;38:273-86.
22. Hall ED, Springer JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004;1:80-100.
23. Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial. Lancet 2004;364:1321-8.